0 NASDAQ Companies - April 24, 2024Katapult Holdings, Inc. Files Annual Report on Form 10-KPLANO, Texas, April 24, 2024 (GLOBE NEWSWIRE) — Katapult Holdings, Inc. (Nasdaq: KPLT) (“Katapult” or the “Company”), today announced the […]Read More
0 NASDAQ Companies - April 24, 2024ChampionX Reports First Quarter 2024 ResultsRevenue of $922.1 million, decreased 3% year-over-year Net income attributable to ChampionX of $112.9 million, increased 78% year-over-year Adjusted net […]Read More
0 NASDAQ Companies - April 24, 2024Marathon Digital Holdings Schedules Conference Call for First Quarter 2024 Financial ResultsEarnings Webcast and Conference Call Set for Thursday, May 9, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, April 24, […]Read More
0 NASDAQ Companies - April 24, 2024Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-KPROVIDENCE, Rhode Island, April 24, 2024 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on April 18, […]Read More
0 NASDAQ Companies - April 24, 2024Amedisys Reports First Quarter 2024 Financial ResultsBATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the […]Read More
0 NASDAQ Companies - April 24, 2024CVB Financial Corp. Reports Earnings for the First Quarter 2024First Quarter 2024 Net Earnings of $48.6 million, or $0.35 per share Return on Average Assets of 1.21% Return on […]Read More
0 NASDAQ Companies - April 24, 2024Riot Announces First Quarter 2024 Earnings Conference CallCastle Rock, CO, April 24, 2024 (GLOBE NEWSWIRE) — Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), an industry […]Read More
0 NASDAQ Companies - April 24, 2024NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingSANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage […]Read More
0 NASDAQ Companies - April 24, 2024NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial ResultsGlobal licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3 Prolonged survival […]Read More
0 NASDAQ Companies - April 24, 2024BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingSAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the […]Read More